12 February 2020 - Aprovel, Differin and Plavix are among the medicines that are withdrawn from the drug benefits at the companies request from 1 March 2020.
Aprovel 150 mg, 28 tablets withdraw from the benefits at the company's request. Parallel distributed packaging remains within the drug benefits.
Aprovel 300 mg, 28 tablets withdraw from the benefits at the request of the company. Generic and parallel distributed packaging remains within the drug benefits.